A Women’s Health Medical Devices Market Research Report has just been published by Market Reports World offering insight into growth markets and unmet needs in the women’s health industry, analysis of trends and of current and future competition in the U.S. market, and looking into what has hindered the adoption of newer technologies, among other things.
It specifically offers physicians’ perspectives, with perceptive quotes from leading gynecologists, urogynecologists, interventional radiologists, and general surgeons from around the world.
The women’s health medical device market includes technologies such as global endometrial devices, endometrial resection devices, uterine fibroid embolization agents, female sterilization devices, and female urinary incontinence slings. These are specifically designed to treat conditions that affect the female anatomy like pelvic disorders such as female stress urinary incontinence and pelvic organ prolapse, as well as menorrhagia and uterine fibroids and permanent forms of birth control.
It is an interesting time to be releasing such a report, with some companies having to shut down their women’s health divisions due to the enormous number of lawsuits that are being brought against the manufacturers of transvaginal mesh devices used to treat pelvic disorders.
According to the FDA, reported complications from the transvaginal mesh include erosion of the mesh into the vaginal tissue, organ perforation, pain, infection, painful intercourse, and urinary and fecal incontinence. Many women have required multiple surgeries to remove the mesh.
All current manufacturers of these devices are in the process of complying with the FDA and undergoing a rigorous premarket approval process where they must demonstrate the safety and effectiveness of their devices or they will be taken off the market.